The genomic basis of myocardial infarctionTOPOL, Eric J.Journal of the American College of Cardiology. 2005, Vol 46, Num 8, pp 1456-1465, issn 0735-1097, 10 p.Article

Interventional cardiology and pharmacology at the crossroads. SymposiumTOPOL, Eric J.The American heart journal. 1995, Vol 130, Num 3, issn 0002-8703, 46 p., 2Conference Proceedings

A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes : Factoring in new trials and meta-analysis dataTOPOL, Eric J.The American heart journal. 2005, Vol 149, Num 4, pp S100-S106, issn 0002-8703, SUPConference Paper

RestenosisTOPOL, Eric J.Progress in cardiovascular diseases. 1997, Vol 40, Num 2, issn 0033-0620, 111 p.Serial Issue

The genetics of heart attackTOPOL, Eric J.Heart (London 1996). 2006, Vol 92, Num 6, pp 855-861, issn 1355-6037, 7 p.Article

Pharmacogenomics in cardiovascular diseasesMUKHERJEE, Debabrata; TOPOL, Eric J.Progress in cardiovascular diseases. 2002, Vol 44, Num 6, pp 479-498, issn 0033-0620Article

Importance of microembolization and inflammation in atherosclerotic heart diseaseYAMADA, David M; TOPOL, Eric J.The American heart journal. 2000, Vol 140, Num 6, pp S90-S102, issn 0002-8703, SUPArticle

Future use of genomics in coronary artery diseaseDAMANI, Samir B; TOPOL, Eric J.Journal of the American College of Cardiology. 2007, Vol 50, Num 20, pp 1933-1940, issn 0735-1097, 8 p.Article

A matter of life and death? The Heart Protection Study and protection of clinical trial participantsMIGRINO, Raymond Q; TOPOL, Eric J.Controlled clinical trials. 2003, Vol 24, Num 5, pp 501-505, issn 0197-2456, 5 p.Article

Economics and quality of care for patients with acute coronary syndromes: The impending crisisTOPOL, Eric J.Clinical cardiology. Supplement (Mahwah, NJ). 2002, Vol 25, Num 1, pp I.9-I.15Article

The fibrillin-1 gene: unlocking new therapeutic pathways in cardiovascular diseaseBARRETT, Paddy M; TOPOL, Eric J.Heart (London 1996). 2013, Vol 99, Num 2, pp 83-90, issn 1355-6037, 8 p.Article

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromesBHATT, Deepak L; TOPOL, Eric J; MD et al.JAMA, the journal of the American Medical Association. 2000, Vol 284, Num 12, pp 1549-1558, issn 0098-7484Article

Pharmacogenomics in clinical practice and drug developmentHARPER, Andrew R; TOPOL, Eric J.Nature biotechnology (Print). 2012, Vol 30, Num 11, pp 1117-1124, issn 1087-0156, 8 p.Article

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitusNISSEN, Steven E; WOLSKI, Kathy; TOPOL, Eric J et al.JAMA, the journal of the American Medical Association. 2005, Vol 294, Num 20, pp 2581-2586, issn 0098-7484, 6 p.Article

Adjunctive therapy for percutaneous revascularization in acute myocardial infarction : Drugs in International CardiologyBRENER, Sorin J; TOPOL, Eric J.Current pharmaceutical design. 2004, Vol 10, Num 4, pp 399-405, issn 1381-6128, 7 p.Article

Current status and future prospects for acute myocardial infarction therapyTOPOL, Eric J.Circulation (New York, N.Y.). 2003, Vol 108, Num 16, pp III.6-III.13, issn 0009-7322, SUPArticle

Need to test the arterial inflammation hypothesisBHATT, Deepak L; TOPOL, Eric J.Circulation (New York, N.Y.). 2002, Vol 106, Num 1, pp 136-140, issn 0009-7322Article

The biology of restenosisBAUTERS, C; ISNER, J. M.Progress in cardiovascular diseases. 1997, Vol 40, Num 2, pp 107-116, issn 0033-0620Article

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialBHATT, Deepak L; TOPOL, Eric J.The American heart journal. 2004, Vol 148, Num 2, pp 263-268, issn 0002-8703, 6 p.Article

The role of proto-oncogenes in coronary restenosisMULLER, D. W. M.Progress in cardiovascular diseases. 1997, Vol 40, Num 2, pp 117-128, issn 0033-0620Article

Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplastyBITTL, J. A.The American heart journal. 1995, Vol 130, Num 3, pp 658-665, issn 0002-8703, 2Conference Paper

Coronary lesions at increased riskELLIS, S. G.The American heart journal. 1995, Vol 130, Num 3, pp 643-646, issn 0002-8703, 2Conference Paper

Prevention of cardiovascular ischemic complications with new platelet glycoprotein IIb/IIIa inhibitorsTOPOL, E. J.The American heart journal. 1995, Vol 130, Num 3, pp 666-672, issn 0002-8703, 2Conference Paper

Restenosis : the cost to societyCALIFF, R. M.The American heart journal. 1995, Vol 130, Num 3, pp 680-684, issn 0002-8703, 2Conference Paper

Thrombospondins, their polymorphisms, and cardiovascular disease : ATVB In Focus: Vascular Adhesion MoleculesSTENINA, Olga I; TOPOL, Eric J; PLOW, Edward F et al.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 9, pp 1886-1894, issn 1079-5642, 9 p.Article